Skip to main content

Animations

MJFF Publications

2521 - 2530 of 8808 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2021
  • 2020
  • 2020
  • 2019
  • 2020
  • 2020
  • 2019
  • Summary Details
    OPEN
    Title: Dual monoamine oxidase B and acetylcholine esterase inhibitors for treating movement and cognition deficits in a C. elegans model of Parkinson’s disease
    Journal Name: Medicinal Chemistry Research
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00044-021-02720-x
    Citation Count: 4
  • Summary Details
    RESTRICTED
    Title: Metabolic Profile in Plasma AND CSF of LEVODOPA-induced Dyskinesia in Parkinson’s Disease: Focus on Neuroinflammation
    Journal Name: Molecular Neurobiology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s12035-021-02625-1
    Citation Count: 16
  • Summary Details
    RESTRICTED
    Title: Dysregulated miRNAs mark Parkinson’s disease progression
    Journal Name: Nature Aging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s43587-021-00046-2
    Citation Count: 1
  • Summary Details
    RESTRICTED
    Title: Quantitative phosphoproteomics uncovers dysregulated kinase networks in Alzheimer’s disease
    Journal Name: Nature Aging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s43587-021-00071-1
    Citation Count: 43
  • Summary Details
    RESTRICTED
    Title: Stereological investigation of 5-HT3 receptors in the substantia nigra and dorsal raphe nucleus in the rat
    Journal Name: Journal of Chemical Neuroanatomy
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jchemneu.2020.101881
    Citation Count: 2
  • Summary Details
    RESTRICTED
    Title: Preferential microglial activation associated with pathological alpha synuclein transmission
    Journal Name: Journal of Clinical Neuroscience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jocn.2020.09.027
    Citation Count: 12
  • Summary Details
    OPEN
    Title: A novel approach to study markers of dopamine signaling in peripheral immune cells
    Journal Name: Journal of Immunological Methods
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jim.2019.112686
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Early postnatal injections of whole vaccines compared to placebo controls: Differential behavioural outcomes in mice
    Journal Name: Journal of Inorganic Biochemistry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jinorgbio.2020.111200
    Citation Count: 5
  • Summary Details
    OPEN
    Title: The Library Derived 4554W Peptide Inhibits Primary Nucleation of α-Synuclein
    Journal Name: Journal of Molecular Biology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jmb.2020.11.005
    Citation Count: 11
  • Summary Details
    RESTRICTED
    Title: Mild cognitive impairment and dementia in motor manifest Huntington's disease: Classification and prevalence
    Journal Name: Journal of the Neurological Sciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jns.2019.116523
    Citation Count: 46
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.